Ribavirin efficiently suppresses porcine nidovirus replication

Area of Science:

• Veterinary Virology
• Antiviral Research
• Molecular Virology

Background:

• Porcine reproductive and respiratory syndrome virus (PRRSV) and porcine epidemic diarrhea virus (PEDV) are significant viral pathogens impacting the swine industry.
• Ribavirin is a broad-spectrum antiviral agent, but its effects on porcine nidoviruses are not well understood.

Purpose of the Study:

• To investigate the antiviral activity of ribavirin against PRRSV and PEDV.
• To elucidate the mechanism of action of ribavirin in suppressing porcine nidovirus replication.

Main Methods:

• Dose-dependent treatment of porcine nidovirus-infected cells with ribavirin.
• Analysis of viral RNA synthesis, protein expression, and progeny virus production.
• Investigation of ribavirin's mechanism via guanosine supplementation and sequencing analysis.

Main Results:

• Ribavirin demonstrated dose-dependent inhibition of both PRRSV and PEDV replication.
• Antiviral effects were observed early in the infection cycle, reducing viral RNA, protein, and progeny.
• Reversal of antiviral activity by guanosine suggests GTP depletion is key; ribavirin did not induce mutations.

Conclusions:

• Ribavirin is a potent inhibitor of porcine nidoviruses, acting via IMP dehydrogenase inhibition and GTP depletion.
• Ribavirin shows promise as a therapeutic agent for PRRSV and PEDV infections.
• Ribavirin warrants further evaluation against other animal and human coronaviruses.